Literature DB >> 7201356

Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma.

S Meijer, N H Mulder, D T Sleijfer, P E de Jong, W J Sluiter, H Schraffordt Koops, G K van der Hem.   

Abstract

We studied renal function in nine patients with disseminated testicular carcinoma before and after remission-induction and maintenance therapy with a drug combination containing cis-platinum. The median glomerular filtration rate (GFR) decreased during remission-induction therapy from 146 to 118 ml/min. No effect of cumulative toxicity on the median GFR was found during maintenance therapy, nor did the median GFR improve. The median effective renal plasma flow (ERPF) decreased during the total period from 705 to 514 ml/min. No significant changes in median filtration fraction (FF) and serum creatinine were observed. It is suggested that intrarenal hemodynamic effects are important in the nephrotoxicity of cis-diamminedichloride platinum (CDDP).

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7201356     DOI： 10.1007/bf00292867

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


  14 in total

1.  A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.

Authors:  A J Donker; G K van der Hem; W J Sluiter; H Beekhuis
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

2.  Uranyl nitrate induced acute renal failure in the rat: effect of varying doses and saline loading.

Authors:  R Ryan; J S McNeil; W Flamenbaum; R Nagle
Journal:  Proc Soc Exp Biol Med       Date:  1973-05

3.  Clinical trials of cis-diamminedichloroplatinum (NSC-119875).

Authors:  A J Lippman; C Helson; L Helson; I H Krakoff
Journal:  Cancer Chemother Rep       Date:  1973-04

4.  Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors.

Authors:  D J Higby; H J Wallace; D J Albert; J F Holland
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

5.  Acute renal failure due to nephrotoxins.

Authors:  N K Hollenberg; D F Adams; D E Oken; H L Abrams; J P Merrill
Journal:  N Engl J Med       Date:  1970-06-11       Impact factor: 91.245

6.  Experimental acute renal failure induced by uranyl nitrate in the dog.

Authors:  W Flamenbaum; J S McNeil; T A Kotchen; A J Saladino
Journal:  Circ Res       Date:  1972-11       Impact factor: 17.367

7.  Mercuric chloride-induced renal failure and intrarenal distribution of blood flow.

Authors:  P Bálint; A Fekete; T Harza
Journal:  Acta Physiol Acad Sci Hung       Date:  1969

8.  Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.

Authors:  G Stoter; D T Sleijfer; C P Vendrik; H Schraffordt Koops; A Struyvenberg; A T Van Oosterom; T M Brouwers; H M Pinedo
Journal:  Lancet       Date:  1979-05-05       Impact factor: 79.321

9.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

10.  Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man.

Authors:  M Dentino; F C Luft; M N Yum; S D Williams; L H Einhorn
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860
View more
  7 in total

Review 1.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

2.  Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function.

Authors:  J J Offerman; S Meijer; D T Sleijfer; N H Mulder; A J Donker; H S Koops; G K van der Hem
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  [The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)].

Authors:  T G Wendt; R Hartenstein; U Büll; K Schlechtweg; E A Moser
Journal:  Klin Wochenschr       Date:  1983-06-01

4.  Cumulative renal tubular damage associated with cisplatin nephrotoxicity.

Authors:  M P Goren; R K Wright; M E Horowitz
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 5.  Role of SLC transporters in toxicity induced by anticancer drugs.

Authors:  Kevin M Huang; Muhammad Erfan Uddin; Duncan DiGiacomo; Maryam B Lustberg; Shuiying Hu; Alex Sparreboom
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-04-26       Impact factor: 4.481

6.  Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl.

Authors:  Ayesha Ahmed; Dalal M Al Tamimi; Anvarhusein A Isab; Abdulaziz M Mansour Alkhawajah; Mohamed A Shawarby
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

7.  Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans.

Authors:  Carmen Martínez-Fernández; Milana Bergamino; Alfonso Schiavi; David Brena; Natascia Ventura; Sebastian Honnen; Alberto Villanueva; Ernest Nadal; Julián Cerón
Journal:  Dis Model Mech       Date:  2022-03-31       Impact factor: 5.758
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.